Soleno Therapeutics, Inc. (SLNO) Misses Q1 EPS by 17c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q1 EPS of ($0.88), $0.17 worse than the analyst estimate of ($0.71).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance
• Duluth Holdings Inc. (DLTH) Tops Q2 EPS by 49c